• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Panbela Therapeutics Inc (NQ: PBLA )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Panbela Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024
    PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
    Developed in collaboration with Sanofi. 
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Recap: Panbela Therapeutics Q4 Earnings
    Via Benzinga
    Earnings Preview: Panbela Therapeutics
    Via Benzinga
    Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
    Trial's lower-than-expected event rate suggests improved survival outcomes 
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela Announces Poster Presentation at American Association for Cancer Research:
    Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models 
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela Announces Transfer to OTCQB Market
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023
    PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Top 4 Health Care Stocks That Are Preparing To Pump This Month
    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
    Via Benzinga
    Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
    Via Investor Brand Network
    Panbela Announces Closing of Approximately $9.0 Million Public Offering
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    What's Going On With Panbela Therapeutics Stock Today?
    Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds. 
    Via Benzinga
    Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
    U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Dow Edges Lower; Cardlytics Shares Jump
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
    U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday. Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Aclarion (ACON) Stock Down 16% Today?
    Aclarion stock is falling on Monday after the company issued 500,000 shares of ACON to cover principal and accrued interest from notes. 
    Via InvestorPlace
    Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
    Panbela Therapeutics stock is falling on Monday after pricing a public offering for PBLA shares well below its price closing price. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
    ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
    Via InvestorPlace
    Panbela Announces Pricing of Approximately $9.0 Million Public Offering
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.